Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPRAGLIFLOZIN L-PROLINE vs IRBESARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPRAGLIFLOZIN L-PROLINE vs IRBESARTAN: Safety Overview

Metric IPRAGLIFLOZIN L-PROLINE IRBESARTAN
Total FAERS Reports 124 10,144
Deaths Reported 9 636
Death Rate 7.3% 6.3%
Hospitalizations 74 5,374
Average Patient Age 62.1 yrs 69.0 yrs
% Female Patients 37.6% 60.2%
FDA Approval Date N/A Apr 17, 2018
Manufacturer N/A Bryant Ranch Prepack
Route N/A ORAL
Marketing Status N/A Discontinued